全文获取类型
收费全文 | 144040篇 |
免费 | 12147篇 |
国内免费 | 8660篇 |
专业分类
耳鼻咽喉 | 1180篇 |
儿科学 | 1843篇 |
妇产科学 | 2795篇 |
基础医学 | 17174篇 |
口腔科学 | 2441篇 |
临床医学 | 18401篇 |
内科学 | 24361篇 |
皮肤病学 | 1670篇 |
神经病学 | 7974篇 |
特种医学 | 4726篇 |
外国民族医学 | 73篇 |
外科学 | 15563篇 |
综合类 | 20276篇 |
现状与发展 | 27篇 |
一般理论 | 10篇 |
预防医学 | 8832篇 |
眼科学 | 4317篇 |
药学 | 14240篇 |
121篇 | |
中国医学 | 6547篇 |
肿瘤学 | 12276篇 |
出版年
2024年 | 375篇 |
2023年 | 2032篇 |
2022年 | 5064篇 |
2021年 | 6502篇 |
2020年 | 4619篇 |
2019年 | 4523篇 |
2018年 | 4629篇 |
2017年 | 4134篇 |
2016年 | 3903篇 |
2015年 | 5803篇 |
2014年 | 7260篇 |
2013年 | 6946篇 |
2012年 | 10151篇 |
2011年 | 11100篇 |
2010年 | 6762篇 |
2009年 | 5385篇 |
2008年 | 7505篇 |
2007年 | 7515篇 |
2006年 | 7591篇 |
2005年 | 7515篇 |
2004年 | 5323篇 |
2003年 | 4970篇 |
2002年 | 4282篇 |
2001年 | 3715篇 |
2000年 | 3802篇 |
1999年 | 3894篇 |
1998年 | 2417篇 |
1997年 | 2344篇 |
1996年 | 1714篇 |
1995年 | 1566篇 |
1994年 | 1368篇 |
1993年 | 893篇 |
1992年 | 1417篇 |
1991年 | 1255篇 |
1990年 | 1093篇 |
1989年 | 964篇 |
1988年 | 822篇 |
1987年 | 770篇 |
1986年 | 595篇 |
1985年 | 525篇 |
1984年 | 292篇 |
1983年 | 211篇 |
1982年 | 164篇 |
1981年 | 154篇 |
1980年 | 112篇 |
1979年 | 159篇 |
1978年 | 91篇 |
1976年 | 62篇 |
1975年 | 75篇 |
1974年 | 78篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
食管癌三维适形后程加速超分割放射治疗的疗效分析 总被引:3,自引:0,他引:3
目的评价三维适形后程加速超分割放射治疗食管癌的疗效及放疗反应、并发症。方法2002年2月至2004年5月,71例食管鳞癌随机分成两组,三维适形后程加速超分割组36例,食管病变上下外约4cm,前后、左右外约0.5~1cm作为PTV1,每次2GY,每周5次,DT40GY后,病变上下外约2cm,前后、左右外约0.5~1cm作为PTV2,每日2次,每次1.5GY,间隔4~6小时,总疗程6周,总剂量67GY/38次。非三维适形后程加速超分割组35例,时间、剂量、分割方式同适形组。所有病例均采用8MV-X外照射。结果1、2、3年的生存率和原发肿瘤的局控率,与非适形后程加速超分割比较,适形组明显提高,分别为88.9%、75%、63.9%比68.6%、51.4%、40%和86.1%、72.2%、58.3%比65.7%、48.5%、34.3%。适形组的急性放射反应明显低于非适形后程加速超分割组,两组有显著差别。结论本研究的初步结果表明食管癌适形后程加速超分割放射治疗的疗效优于非适形后程加速超分割组。 相似文献
102.
BACKGROUND/PURPOSE: Abdominal nontuberculous mycobacterial infection is a rare condition. Continuous ambulatory peritoneal dialysis (CAPD)-associated peritonitis is the most common manifestation of infection due to nontuberculous mycobacteria (NTM). There are limited data on the clinical manifestations of nontuberculous mycobacterial infection. This study investigated the diagnostic features, clinical presentation, mycobacteriology, treatment and outcome of all abdominal NTM infections treated over a 7-year period at a major teaching hospital in Taiwan. METHODS: The medical records of all patients with a diagnosis of abdominal NTM infection from January 1997 through to December 2003 were retrospectively reviewed. RESULTS: All 11 patients with abdominal NTM infections identified during the 7-year period were included. Among these patients, six were male and five were female, with a mean age of 64.5 years. The disease manifested as peritonitis (9 patients, 82%), splenic abscess (1, 9%), or perirenal abscess (1, 9%). Most patients (73%) had underlying malignancy, most often hepatoma (45%). Immunocompromised status (liver cirrhosis, malignancy, acquired immunodeficiency syndrome) was noted in 10 patients (91%). None of our patients who developed NTM peritonitis had received CAPD. The peritoneal fluid appearance varied considerably, with no particular predominance of clear, turbid, bloody, or chylous findings. Rapidly growing mycobacteria were the major etiology (46%) of abdominal NTM infection, and Mycobacterium abscessus played a major role (27%). Overall, eight patients died, and only one patient survived longer than 1 year. Seven patients (64%) died before diagnosis. CONCLUSION: Abdominal NTM infection is frequently overlooked because of its rarity and nonspecific symptoms, with consequent delays in diagnosis and treatment. In immunocompromised patients with ascites from any cause (liver cirrhosis, malignant ascites, etc.), NTM peritonitis should be considered early in the differential diagnosis of symptoms including fever, abdominal pain and weight loss. The poor prognosis of abdominal NTM infection appears to be related to the severity of underlying conditions, most often malignancy. 相似文献
103.
Our purpose was to determine the effects of six cigarette toxicants (pyridine, nicotine, 2-ethylpyridine, 3-ethylpyridine, p-cresol, and pyrazine) on three types of cultured mammalian cells (human umbilical vein endothelial cells [HUVECs], human microvascular endothelial cells [HMVECs], and NIH 3T3 cells) using a cell proliferation/survival assay. Synchronized cells were cultured in proliferation or survival medium containing various doses (10(-18)M-10(-2)M) of the tested chemicals. After 48 h, cells were counted using a hemacytometer. The no observable adverse effect level (NOAEL), lowest observable adverse effect level (LOAEL), and the efficacy were determined for each compound in the cell proliferation and survival assays. Pyridine and p-cresol did not show significant effects with any cell types, except at high doses. Derivitization of the pyridine ring altered its potency, especially when an ethyl group or nitrogen was added. In survival medium, nicotine stimulated proliferation of all three cell types at doses found in smoker's serum (10(-8)M-10(-7)M). For HUVEC and HMVEC, 2-ethylpyridine, 3-ethylpyridine, and pyrazine inhibited proliferation in proliferation medium and induced cell death in survival medium at attomolar and femtomolar doses. All chemicals, except pyridine and pyrazine, stimulated NIH 3T3 cell proliferation at low doses and induced cell death at high doses. LOAELs and efficacies revealed that endothelial cells from a developing organ (umbilical cord) were more sensitive to these chemicals than endothelial cells from an adult organ (lung). 3-Ethylpyridine and pyrazine, which induced cell death at low doses, are added to consumer products and should be subjected to further toxicological testing. 相似文献
104.
目的: 观察细胞内游离Ca2+([Ca2+]i)在培养的不同发育阶段皮层神经元无镁诱导惊厥性损伤中的作用,探讨惊厥性脑损伤年龄依赖性的可能机制.方法:体外培养6 d、17 d的胚胎大鼠皮层神经元用无镁细胞外液处理3 h,或于无镁处理前用NMDA(N-甲基-D-门冬氨酸)受体拮抗剂或Ca2+通道阻滞剂预处理,用MTT代谢率测定的方法检测神经元损伤,以Fluo-3作标记用激光共聚焦显微镜扫描的方法检测[Ca2+]i.结果:体外培养6 d、17 d的神经元单纯无镁组MTT代谢率较同期对照组降低.应用MK-801 10 μmol*L-1、AP-5 50 μmol*L-1、尼莫地平10 μmol*L-1预处理后再给无镁处理,培养6 d、17 d的神经元MTT代谢率均不同程度高于同期单纯无镁组.培养6 d、17 d的神经元相对荧光强度之间差异有显著性,两者与基线荧光强度比较差异亦有显著性.应用上述各种拮抗剂后,[Ca2+]i改变的峰值均明显低于同期单纯无镁组.结论: 在体外不同发育阶段的神经元,短暂无镁处理诱导惊厥样放电所引起的神经元线粒体功能损伤以及[Ca2+]i改变程度不同.这种[Ca2+]i改变的年龄依赖性可能是惊厥导致神经元损伤的年龄依赖性的机制之一.NMDA受体-Ca2+通道激活是导致这种[Ca2+]i改变及神经元损伤的关键环节. 相似文献
105.
106.
临床科室工作量评价方法及其应用 总被引:5,自引:1,他引:4
目的:探讨测量、评价临床科室工作量的指标和方法,加强医院科室管理,促进效益评价与核算。方法:应用医院病案和报表资料,每月计算科室工作强度指数并进行排位,用相对比方法初步分析科室临床工作量和排位变动的状况。结果:选取了实际占用床位数、危重病人抢救次数、门急诊人次数、出会诊人次数、出院病人数5项指标,计算出各科室工作强度指数和排位,并对各科室工作量排位变动进行了比较。结论:临床工作量评价指标和方法的代表性、灵敏性和可靠性较好,实际评价效果也较客观地反映了各临床科室的实际工作量大小。 相似文献
107.
Poly-L-Lysine玻片在寡核苷酸芯片制备中的改进 总被引:1,自引:0,他引:1
目的 为了制得适合固定未修饰寡核苷酸的芯片,提高检测灵敏性,对Patrick Brown实验室的多聚左旋赖氨酸包被玻片的方法进行改进。方法 玻片经清洗后用缩水甘油-丙氧基三甲氧基硅烷进行硅烷化,然后应用Poly-L-Lysine在玻片表面形成聚合物涂层,经次亚苯基二异硫氰酸盐表面活化后可使寡核苷酸共价连接在芯片表面。设计了各种实验考察方法改进前后芯片表面的性能,并将改进后的玻片初步应用于SARS冠状病毒寡核苷酸芯片检测中。结果 方法改进后芯片表面性能优良:固定效率高、点的同一性好、杂交效率和热稳定性好、寡核苷酸结合牢固、芯片可以重复利用。结论 利用共价连接,方法改进后的芯片表面适合固定未修饰的寡核苷酸,解决了寡核苷酸与玻片之间物理结合不稳定、易剥离的缺陷,提高了芯片检测的灵敏性。 相似文献
108.
Jianhua Yan Zhongyao Wu Eye Hospital Zhongshan Ophthalmic Center Sun Yat-sen University Guangzhou China 《眼科学报》2003,19(3):174-175
Purpose:To report a rare sign, paracentral corneal dellen that developed in a middleaged female patient with Graves ophthalmopathy.Methods:A paracentral corneal dellen developed in the left eye in a 42-year-old woman who was diagnosed as Graves ophthalmopathy. The patient had remarkable upper eyelid retraction, upper eyelid lag and upward motility restriction. The Graves ophthalmopathy was classified as Grade Ⅳ according to NOSPECS classification.Results:Local artificial tear film and 0.3% Tobramycin eye drops were administered to both eyes.Twenty-four hours later, the left corneal dellen disappeared.Conclusions:Graves ophthalmopathy can lead to paracentral corneal dellen because of severe upper eyelid retraction and upward motility restriction of the eye in spite of the lack of lagophthalmos. Artificial tear drop and antibiotic eye drop therapy helped even though the patient did not have corneal exposure. Eye Science 2003;19:174-175. 相似文献
109.
三维适形放射治疗局部复发鼻咽癌疗效观察 总被引:11,自引:2,他引:9
目的:观察三维适形放疗治疗局部复发鼻咽癌的近期疗效及放射损伤的发生率。方法:对42例局部复发鼻咽癌病例采用三维统计计划系统放射治疗计划,以剂量体积直方图评价和优化放射治疗计划,头部固定装置及多叶光栅技术实施适形放射治疗。计划靶区为临床所见肿瘤区外放7-10mm,计划靶区体积(PTV)中位体积为47.6cm^2(27.9-61.8cm^3),时间-剂量-分次采用:(5-5.5周)-(60-70Gy)-(24-28次),结果:三维适形放疗后,肿瘤局部控制率85.7%(36/42),2年生存率73.8%(31/42),放射损伤包括听力丧失7.1(3/42),张口困难35.7%(15/42),吞咽困难7.1%(3/42),慢性副鼻窦炎28.6%(12/42),脑神经损伤21.4%(9/42),结论:三维适形放疗治疗鼻咽放疗后鼻咽部局部复发有较好的近期疗效,而放射损伤较低,远期疗效尚待进一步观察。 相似文献
110.